Study of clinical mastitis in British dairy herds with bulk milk somatic cell counts less than 150,000 cells/ml

A 12-month prospective study of clinical mastitis was conducted in 482 British dairy herds with a bulk milk somatic cell count (BMSCC) of less than 150,000 cells/ml. The mean proportion of cows in the herd with clinical mastitis was 23.1 per cent (range 0 to 80), with a mean of 1.50 quarter cases per cow. The mean incidence rate of clinical mastitis was 36.7 quarter cases per 100 cow years (range 0 to 208.2). Twelve per cent of the quarter cases showed systemic signs, including inappetence and severe lethargy. Over 22 per cent of quarter cases occurred in the first seven days of lactation and over 50 per cent occurred in the first 90 days of lactation. Cluster analysis indicated that the main difference between herds with a low and average incidence of mastitis was the proportion of clinical cases occurring in the first seven days of lactation, 14 per cent compared with 44 per cent, respectively. The risk of severe clinical mastitis compared with mild clinical mastitis decreased significantly as the individual cow somatic cell count (SCC) in the month before clinical mastitis was diagnosed increased.     

奶牛隐性乳房炎的调查分析

采用体细胞计数(SCC)法对杨凌某奶牛场中60头不同胎次和泌乳时间奶牛隐性乳房炎进行检测,对引起乳房炎的可能诱因进行调查分析,研究该场奶牛隐性乳房炎的发病规律,为本病的防控提供参考。结果表明,受检奶牛隐性乳房炎的检出率为43.3%。1胎～2胎奶牛隐性乳房炎检出率为40.0%,3胎～4胎为46.7%,隐性乳房炎的检出率有随胎次增加而升高的趋势;泌乳时间少于200 d的泌乳牛隐性乳房炎检出率为27.6%,200 d～300 d的为36.4%,300 d～400 d的为41.7%,超过400 d的为50.0%,提示奶牛隐性乳房炎有随泌乳期升高的趋势。本调查显示,奶牛隐性乳房炎的发生与胎次和泌乳时间有显著的相关性,饲养管理和卫生条件是乳房炎发生的重要诱因。     

隐性乳房炎试验(CMT)及防治方案

[目的]为找出陕西地区奶牛隐型乳房炎的临界点。[方法]采用生产上常用的乳房炎诊断方法,通过间接测定乳中体细胞数来诊断乳房炎的发生。[结果]找出体细胞数在47.46万以上时才依次表现出弱阳性、阳性、强阳性的特征。[结论]从而依据以上结果制定出两种方案用于预防和治疗乳房炎的发生。     

DHI体系在奶牛生产中的作用效果分析

为了发挥DHI体系在奶牛生产管理中的作用,促进奶牛健康养殖和乳品质量的提高,本研究利用DHI技术对包头某奶牛场6个月的奶牛生产情况进行了分析。结果发现,该奶牛场奶牛的乳脂率较低,体细胞数较高,一些奶牛患有严重的临床性乳房炎或隐性乳房炎。奶牛营养状况差,泌乳高峰期到达时间晚,产奶量少,存在潜在的奶损失。针对上述问题,提出了相应的解决措施。     

Aetiology of clinical mastitis in six Somerset dairy herds.

Clinical mastitis was monitored in six Somerset dairy herds for one year. The herds all had three-month geometric mean bulk milk somatic cell counts of less than 250,000 cells/ml. Escherichia coli was the predominant pathogen isolated on all the farms and in all months of the year. Environmental pathogens accounted for 61.4 per cent of all cases of clinical mastitis and for 79.3 per cent of the mastitis cases in which an aetiological agent was identified. The mean annual incidence was 41.6 cases per 100 cows (range 14 to 75). Affected cows suffered a mean of 1.5 cases and 16.4 per cent of quarters suffered at least one repeat case. Mastitis due to E. coli was more severe than mastitis due to other causes and it tended to be more severe in early lactation and during the housing period. Mastitis was significantly more severe (grades 2 and 3) in the herd with the lowest bulk milk somatic cell count and in the herd which was kept indoors throughout the year than in the other four herds. Mastitis was fatal in 2.2 per cent of cases and resulted in the death of 0.6 per cent of the lactating cows.     

A survey of mastitis in selected ontario dairy herds

A mastitis survey involving 74 Ontario dairy herds was conducted. The prevalence of infection at the quarter level was found to be 4.1% with Streptococcus agalactiae, 4.5% with other streptococcal species and 8.0% with Staphylococcus aureus. Regardless of the infection status, the geometric mean somatic cell count was found to increase with age of the cow but no increase was observed with increasing stage of lactation. The percentage of cows from which a bacterial pathogen was isolated increased with age but not with stage of lactation.     

Relationship between milk production and somatic cell count in dairy cows in East Gippsland

SUMMARY The analysis of records for 75 821 herd tests on 23 700 cows in the Macalister Irrigation District of East Gippsland, using a model that also included stage of lactation, herd and cow effects, found a strong relationship between somatic cell count and milk production. Unit increases in the natural logarithm of the somatic cell count were associated with decreases in production of up to 2.6% in the range 54 598 to 403 429 cells per mL. This is equivalent to a decrease of 1.9% for a doubling of cell count from 100 000 to 200 000 cells per mL. Subclinical mastitis was assessed to be a significant source of loss in milk production in the study area.     

Management factors associated with the incidence of clinical mastitis over the non-lactation period and bulk tank somatic cell count during the subsequent lactation

Aim: To evaluate associations between management decisions related to the control of mastitis, including the infusion of antibiotics at the end of lactation (dry-cow therapy; DCT), on the incidence of clinical mastitis over the non-lactating period and the bulk tank somatic cell count (BTSCC) in the subsequent lactation. Methods: Dairy herd owners (n=158) provided information via a retrospective survey about (a) the proportion of their herds treated with DCT; (b) DCT management, including: number of occasions on which cows were dried off; manipulation of feed and water intake around drying off; infusion technique (partial vs full depth insertion of cannula); and hygiene before and after DCT infusion; (c) occurrence of mastitis and frequency of occurrence following drying off and in the subsequent lactation; (d) number of cows culled for mastitis-related conditions; (e) reasons for culling; (f) incidence of clinical mastitis; and (g) stock purchase policy with regard to mastitis. The BTSCC for each vat of milk supplied for the 1999/2000 and 2000/2001 seasons, and records of antibiotic purchases were collated for each herd. The probability that >2% of cows within a herd were diagnosed with clinical mastitis over the dry period was initially examined using univariate analysis (i.e. chi2 or logistic regression) and associated factors (p<0.2) were offered to a reverse stepwise logistic regression model. Factors hypothesised as being associated with the average lactation log10 BTSCC for the 2000/2001 season were initially examined using univariate analysis (i.e. ANOVA or linear regression analysis) and associated factors (p<0.2) were then tested using a forward manual model-building approach. Results: Increasing the percentage of the herd treated with DCT at the end of lactation was associated with reduced probability that >2% of a herd would be diagnosed with clinical mastitis over the non-lactating period and with a lower BTSCC in the subsequent lactation (p<0.01). A lower BTSCC was associated with small herds (<150 cows; p<0.05), not reducing feed intake around drying off (p<0.05), checking for clinical mastitis over the dry period in the milking parlour rather than at pasture (p<0.05), partial insertion of the DCT cannula (p<0.01), and use of 'change in udder shape' during lactation as a diagnostic criterion for mastitis (p<0.05). The incidence of clinical mastitis over the dry period was positively associated with reduced feeding around drying off (p=0.05) and the estimated volume of milk being produced at the time of drying off (p=0.014). Conclusions: Use of dry cow therapy was associated with fewer cases of clinical mastitis over the non-lactating period and reduced BTSCC over the subsequent lactation. Reduced BTSCC was also associated with smaller herds, use of partial (compared with full depth) insertion of the DCT cannula, not reducing feed intake at the time of drying off, checking for clinical mastitis over the dry (non-lactation) period in the milking parlour, and use of udder shape for diagnosis during lactation. Control of clinical mastitis and BTSCC involves a range of management practices that need to be used in conjunction with DCT. Keywords: Dairy cows, mastitis, dry-cow therapy, somatic cell count, management practices.     

A clinical trial to evaluate the effectiveness of antibiotic treatment of lactating cows with high somatic cell counts in their milk

OBJECTIVE: To determine the effectiveness of treatment of lactating cows with high somatic cell counts in milk. DESIGN: Randomised clinical trial. METHODS: Single pooled quarter samples of milk were obtained from cows with somatic cell counts above 500,000 cells/mL on fifty farms. Milk samples were cultured for known mastitis bacterial pathogens. Cows were randomly allocated to treated and untreated groups. Treated cows received both intramammary cloxacillin and parenteral erythromycin. Single pooled quarter milk samples were obtained at 6 weeks after treatment and were cultured for the presence of pathogenic bacteria. The percentage of samples with no growth at the post-treatment culture was used as an estimate of the bacteriological cures for each pathogen type and for each treatment group. Somatic cell counts of cows were compared between treatment groups and within pathogen group. The number of cows that completed a full lactation were compared between each treatment group and within each pathogen group. RESULTS: Treatment had no effect upon bacteriological cures, irrespective of pathogen present or the presence of bacteria during the previous lactation. There was no effect of treatment upon somatic cell count except for cows infected with Streptococcus dysgalactiae in which treatment caused a significant lowering of cell counts. This effect was not present in the subsequent lactation. Treatment of chronically infected cows did not alter the probability of a cow completing a full lactation but did improve the probability of newly infected cows being retained for the next lactation. Twenty-eight of 214 treated cows developed clinical mastitis in more than one quarter after treatment, thus indicating a poor technique by farmers for the insertion of intramammary antibiotics. CONCLUSIONS: Treatment during lactation of cows with high somatic cell counts in milk is ineffective in reducing bacterial infections and in reducing somatic cell counts to acceptable numbers.     

Costs associated with selected preventive practices and with episodes of clinical mastitis in nine herds with low somatic cell counts

Nine dairy herds (mean size, 149 cows) with bulk-tank milk somatic cell counts of less than 300,000 cells/ml and greater than 80% of cows with Dairy Herd Improvement Association linear somatic cell counts less than or equal to 4 were selected for study. Each herd was monitored for 12 consecutive months. Duplicate quarter-milk specimens were collected from each cow for bacteriologic culturing at beginning of lactation, cessation of lactation, and at the time of each clinical episode of mastitis. Streptococcus agalactiae was never isolated and Staphylococcus aureus was isolated from less than 1% of all quarters. There were 554 episodes of clinical mastitis. During the year of study, the incidence rate of clinical mastitis varied from 15.6 to 63.7% of cows among the 9 herds. Mean costs per cow per year in herd for mastitis prevention were: $10 for paper towels, $3 for nonlactating cow treatment, and $10 for teat disinfectants. Mean cost associated with clinical mastitis was $107/episode. Approximately 84% ($90) of the costs attributed to a clinical episode were associated with decreased milk production and nonsalable milk. Costs of medication and professional veterinary fees per clinical episode varied significantly among the 9 herds. Three of the herds did not have a veterinarian treat a clinical episode of mastitis during the year of study even though 2 of these herds had the first and third highest incidence rates of clinical mastitis. When calculated on a per cow in herd basis, mean costs of $40/cow/year were attributed to clinical mastitis.(ABSTRACT TRUNCATED AT 250 WORDS)     

Drying off cows: a comparative study with two dry cow products

From September 1998 to September 1999, at drying off 397 cows on 73 Dutch farms were treated, with two antibiotic containing dry cow products (cloxacillin; penicillin-neomycin). Farms and cows were selected on an increased bulk milk somatic cell count (BMSCC) and individual cow somatic cell count. The objective of the trial was to compare the efficacy of both products under field conditions. Both products proved to be highly effective against streptococci and penicillin sensitive staphylococci. Because of the low incidence of infections caused by Escherichia coli and penicillin resistant staphylococci no conclusions could be drawn on differences in activity for these two pathogens. No significant differences were found between the two products in cure rate of existing infections at drying off, incidence of new infections during the dry period, incidence of clinical mastitis during the dry period and the course of the individual cow cell counts during the trial.     

Microbiologic investigation of an epizootic of mastitis caused by Serratia marcescens in a dairy herd.

An epizootic of subclinical and clinical mastitis caused by Serratia marcescens was investigated in a 1,000-cow dairy farm in California. Serratia marcescens was isolated from 13 to 18% of composite milk samples obtained from lactating dairy cows. During monthly milk sampling performed during a 4-month period, S marcescens was isolated from 38.8 to 62.3% of composite milk samples obtained from cows from which S marcescens was previously isolated. Few cows infected with S marcescens had evidence of clinical mastitis. Somatic cell count value was associated with isolation of S marcescens. Cows with somatic cell counts greater than 500,000 were 5.48 times as likely to have intramammary infections with S marcescens, compared with cows with somatic cell count less than or equal to 500,000. Lactation number also was associated with S marcescens intramammary infection. After adjusting for the effect of lactation number, cows with high somatic cell count values were 2.98 times as likely to have intramammary infection with S marcescens, compared with cows with low somatic cell counts. Infection with S marcescens was independent of days in lactation, production string, and daily milk production. Eleven months after the beginning of the epizootic, S marcescens was isolated from organic bedding samples obtained from the dairy. Despite numerous attempts, other sources of S marcescens could not be identified on this dairy.     

Intramammary treatment of clinical mastitis of dairy cows with a combination of lincomycin and neomycin, or penicillin and dihydrostreptomycin

AIM: To compare clinical and bacteriological cure rates of clinical mastitis following treatment with intramammary preparations containing either lincomycin and neomycin or penicillin and dihydrostreptomycin. METHODS: Cases of clinical mastitis were sourced from four seasonal-calving dairy herds in the central Waikato region of New Zealand during the first 120 days of lactation. Affected quarters were infused three times at 12 h intervals with either 333 mg lincomycin plus 100 mg neomycin (lin/neo; 197 glands),or 1,000 mg penicillin plus 500 mg dihydrostreptomycin (pen/DHS; 207 glands). Milk samples were collected for bacteriology from each quarter immediately before and approximately 21 days after initiation of treatment. Additionally, a composite milk sample from each cow was collected, on average, 54 days after enrolment for assessment of milk yield, composition and somatic cell count (SCC). The probability of bacterial cure was initially analysed using Chi-squared analysis, and factors that were associated (p<0.2) were offered to a reverse stepwise logistic regression model. Continuous variables (e.g. milk solids production and log10 SCC) were analysed using general linear models. RESULTS: A total of 404 quarters diagnosed with clinical mastitis, from 282 cows in the first 120 days of lactation, were included. Streptococcus uberis, coagulase-negative staphylococci and Staphylococcus aureus were isolated from 56.5%, 18.8% and 10.0% of the bacteriologically positive quarters. There was no difference in the bacteriological cure rate (76.7% vs 76.7%, OR=0.94; p>0.8), the log10 SCC (2.1, SE 0.1, vs 2.0, SE 0.1; p>0.3) or milk production (1.2, SE 0.1, vs 1.2, SE 0.1, kg milksolids/cow/day; p>0.7) between lin/neo vs pen/DHS treatments, respectively. However, the proportion of cows re-treated following initial treatment was higher for the lin/neo compared to pen/DHS-treated group (16.3% vs 5.2%, OR=3.46; p<0.05). CONCLUSIONS: No difference in bacteriological cure rate, milk production or SCC was evident between lin/neo and pen/DHS intramammary treatments for clinical mastitis in dairy cows during the first 120 days of lactation. KEYWORDS: Dairy cow, mastitis, intramammary, antibiotic, treatment, somatic cell count.     

Prevalence of clinical mastitis in 38 Waikato dairy herds in early lactation

AIM: To determine the prevalence of clinical mastitis in spring-calving dairy herds in the Waikato Region of New Zealand and to identify factors associated with variation in the prevalence of clinical mastitis between herds. METHOD: A total of 799 quarters from 595 dairy cows from 38 dairy herds were diagnosed by herd owners as having clinical mastitis between 8 July and 21 August 1997. Quarters diagnosed with clinical mastitis were sampled for bacterial culture and somatic cell count, and the presence of clots in the milk and the presence of udder oedema were assessed by a technician or veterinarian. RESULTS: Clinical mastitis was diagnosed in an average (+/-s.e.m.) of 9.9% (+/-0.8%, range 0.9-21.4%) of calved cows within the herds. Bacteria were not cultured from an average of 12.4 % (+/- 2.0%, range 0.0-45.5%) of cows and 22.3% (+/- 2.4%, range 0.0-54.0%) of quarters diagnosed as having clinical mastitis. There were significant differences between herds in the proportion of cows diagnosed with mastitis and in the proportion of clinical mastitis cases from which bacteria were not cultured. A decreased prevalence of clinical mastitis (p<0.001) was associated with an increased percentage of the herd treated with dry cow antibiotics. An increased prevalence of clinical mastitis (p<0.0001) was associated with both an increased percentage of cows treated in the previous season with lactating cow antibiotics and an increased percentage of heifers in the herd. Herds that were fed supplements before or during lactation had a higher prevalence of clinical mastitis than herds that were not fed supplements (p<0.001). An increased proportion of quarters diagnosed with clinical mastitis that did not culture bacteria was associated with an increased prevalence of clinical mastitis (p<0.001). The proportion of quarters that the technician or veterinarian found with evidence of clinical mastitis (i.e. a somatic cell count >500,000 cells/ml and the presence of either clots or udder oedema) within a herd was inversely related to the proportion of quarters within a herd from which no bacteria were isolated. CONCLUSION: There was a large variation in the prevalence of clinical mastitis and in the proportion of clinical quarters from which no bacteria were grown between herds. Management factors such as the use of dry cow therapy, feeding regimes and heifer replacement rates all affected the prevalence of clinical mastitis. Herd owners appear to differ in the sensitivity and specificity of their diagnosis of clinical mastitis, with bacteria not isolated from up to 50% of quarters diagnosed with clinical mastitis in some herds. Improvements in the specificity of herd owner diagnosis of clinical mastitis may reduce the use of antibiotics for mastitis during lactation and hence may reduce the risk of antibiotic contamination of milk supplied for human consumption.     

Somatic cell counts: associated factors and relationship to production.

Factors affecting somatic cell counts and the association between somatic cell counts and milk production were evaluated. Data were collected from 748 Ontario Dairy Herd Improvement Corporation supervised herds that were on production and somatic cell count programs between April 1981 and March 1983. Two data files were created; one, the lactation summary file, contained one record per cow on each of 9406 Holsteins and the other, the test day file, included results of all tests during the complete lactation on each of the above cows. The latter file contained 85,236 records. Multiple curvilinear least squares regression was used to create five separate models. The dependent variables used in the models were natural logarithms (Loge) of the geometric mean of the somatic cell count for the lactation, 305 day milk production and breed class average for milk from the lactation summary file, and loge of the 24 hour somatic cell count and 24 hour milk production from the test day file. The somatic cell count at both the lactation and test day level increased with age up to approximately ten years and thereafter slowly decreased. The variable "days in milk" was not significantly associated with the lactation average somatic cell count. A curvilinear relationship was found between days in lactation at the time of test and the somatic cell count of 24 hour milk production. The somatic cell count increased until approximately 250 days in lactation and thereafter slowly decreased. It was found that the highest cell counts occurred in summer and the lowest in winter.(ABSTRACT TRUNCATED AT 250 WORDS)     

Factors prior to dry period associated with high and low levels of cow milk somatic cell counts in next lactation

Data from a randomized controlled field study of selective dry cow therapy were used in which 686 cows had been allocated to 2 control groups (sampling only or placebo) or 2 therapy groups. Possible factors from previous lactation were assessed in determining their association with the probability of 'failure', designated as a cow milk somatic cell count (CMSCC) of greater than 399,000 per ml in geometric mean of several measurements during subsequent lactation. Success cows were those with a CMSCC of less than 200,000 per ml. For our analyses, this targeted 187 success cows and 186 failure cows. Therapy was given as a total dose of 400,000 IU penicillin and 100 mg neomycin per infected quarter as dry cow preparation once, or as a lactation formula with a total dose of 1.2 million IU penicillin and 1,200 mg dihydrostreptomycin per infected quarter during a 1-week period. Significant factors in the predictive model for success included therapy, low level of CMSCC (geometric mean of the 3 last tests) in previous lactation, low level of CMSCC (weighted by daily milk yield mean) in the herd, young cows, and not having had a case of treatment for chronic clinical mastitis. Additional information on the probability of failure in treated and untreated cows can be predicted by number of quarters infected with Staphylococcus aureus approximately 1.5 months before drying off. The models derived are considered for use as tools in selective treatment and culling decisions.     

Dry cow therapy with a non-antibiotic intramammary teat seal - a review

: Dry cow antibiotic therapy is used to eliminate existing intramammary infections and to prevent new infections in the dry period. It is implemented as part of a total management system known as the 'Five-Point Plan' for mastitis control. Recent public concerns over the widespread prophylactic use of antibiotics, coupled with an increasing interest in organic farming, have lead to a re-evaluation of the treatment of cows at drying-off. As a result, attention has focussed on the use of novel alternatives to antibiotic therapy at the end of lactation. One such therapy involves the application of a non-antibiotic bismuth-based intramammary teat seal designed for use in cows with low cell counts at the end of lactation. Like the keratin plug that forms naturally in teats of cows that have been dried-off, teat seal forms a physical barrier to invading pathogens. To date, a number of independent studies have shown that teat seal is as effective as traditional dry cow antibiotic products in preventing the occurrence of new infection during the dry period in cows with somatic cell counts of ≤200,000 cells ml-1 at drying-off. This paper reviews the efficacy of teat seal in preventing dry period mastitis in both conventional and organic dairying systems.     

The prophylactic effect of a teat sealer on bovine mastitis during the dry period and the following lactation

AIM: To determine the prophylactic efficacy of a teat sealer, administered at drying off, in reducing new intramammary infections in the dry period and the following lactation. METHODS: A total of 528 cows with late lactation somatic cell counts <2 00,000 cells/ml was identified in three commercial herds. Of these, bacteriological examination showed 482 cows were uninfected in all four quarters and 46 were infected in only one quarter. At drying off, uninfected quarters were randomly allocated to the following treatments: no infusion (negative controls), infusion with a bismuth subnitrate based teat sealer, infusion with teat sealer + antibiotic, or infusion with a cephalonium-based dry cow antibiotic (positive control). New infections were identified during the dry period by periodic udder palpations and at calving by bacteriological culture. RESULTS: All three infused treatments reduced the incidence of new intramammary infections due to Streptococcus uberis, both during the dry period and at calving, by about 90% (p <0.01). The majority of the infections were due to Streptococcus uberis. For all treatments, a 50% lower incidence of clinical mastitis over the first 5 months of the ensuing lactation was reported by farmers. X-ray imaging of 19 teats showed that the teat sealer material was retained, at least in part, in the lower teat sinus over about 100 days of the dry period. CONCLUSIONS: Closure of the teat canal from day one of the dry period as achieved by the teat sealer was as effective in reducing new dry period infections as the infusion of a long-acting dry cow antibiotic formulation. The lower incidence of new infections in the ensuing lactation among the infused quarters implies that fewer subclinical infections persisted from the dry period. Use of teat sealers at drying off appears to offer the same prophylactic efficacy as the dry cow antibiotic approach.     

The association between high milk somatic cell counts in the first lactation and somatic cell counts in the second lactation

With the advent of web-based recording and analysis systems, individual cow composite somatic cell count (SCC) data are being increasingly used for decision support in mastitis control at both the individual cow and herd level. SCC data from first and second lactation dairy cows (n=1912) from 12 farms were analysed using multinomial logistic regression to investigate possible associations between high SCC patterns in the first lactation and the subsequent lactation. Animals with three non-consecutive counts >200,000 cells/mL in their first lactation were significantly more likely to have three non-consecutive counts >200,000 cells/mL (OR 3.11; 95% CI 1.72-5.62) or three consecutive counts >200,000 cells/mL (OR 2.00; 95% CI 1.09-3.68) in their second lactation. Similarly animals with three consecutive counts >200,000 cells/mL in their first lactation were significantly more likely to have three non-consecutive counts >200,000 cells/mL (OR 1.90; 95% CI 1.13-3.19) or three consecutive counts >200,000 cells/mL (OR 4.14; 95% CI 2.81-6.08) in their second lactation. These findings suggest that patterns established in the first lactation may have an impact on udder health in the subsequent lactation. However, simulation modelling of positive predictive values for the first lactation cell count patterns as predictors of second lactation patterns demonstrated that, at prevalences likely to be encountered on UK dairy farms, the associations were not a sufficient basis for major management decisions such as culling.     

Environmental and managerial determinants of somatic cell counts and clinical mastitis incidence in Ohio dairy herds

A stratified-random sample of 48 Ohio dairy herds participated in a 1-year disease monitoring survey to study herd management and environmental conditions affecting udder infection and clinical mastitis incidence. The mean monthly bulk-tank somatic cell count was used as an indicator of overall udder infection. Clinical incidence was determined by monthly on-farm interviews with the dairy producers. Management and environmental conditions were assessed by direct observation as well as by personal interview of dairy managers. The final multivariable analysis-of-variance model of log bulk-tank somatic cell count had an R² value of 0.43. Lower log bulk-tank somatic cell count was found in herds with hired milkers, a clean and dry cow exercise area, clean teats following milking and fewer milking cows. The number of months spent on pasture was also significant. The final model for clinical mastitis incidence had an R² value of 0.38. Less clinical mastitis was found on farms where straw bedding was used, pre-dip was not used, where there were fewer cows, fewer person-hours per cow were spent milking cows, a greater percentage of calvings occurred in the designated calving facility, and cows spent fewer months per year on pasture. Other potentially important disease determinants could not be included in the final models because of limited sample size relative to the model degrees of freedom (six each).